Physician profile
Erica F Bisson
NPI 1750409520
$240,128.05
in general payments reported to CMS, 2019-2025
9 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $22K · 2021: $77K · 2022: $47K · 2023: $20K · 2024: $1,577 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Royalty Or License: $13K · Travel and Lodging: $3,601 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $725 · Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,231.82 |
| Royalty Or License | $13,361.17 |
| Travel and Lodging | $3,601.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $725.00 |
| Food and Beverage | $344.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $134,001.54 | 2019-2025 | 1688, Target |
| Mirus, LLC | $46,739.16 | 2019-2025 | Europa Pedicle Screw System, Cygnus Anterior Cervical Plate |
| Medtronic, INC. | $46,512.21 | 2021-2023 | |
| Vb Spine LLC | $10,525.89 | 2025 | Vulcan Spinal System |
| Nuvasive, INC. | $1,401.14 | 2019-2022 | |
| Medtronic USA, INC. | $871.04 | 2019 | |
| Depuy Synthes Sales INC. | $52.61 | 2024 | Teligen, Viper, T-Plif |
| Medical Device Business Services, INC. | $24.46 | 2024 | Teligen |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$193,182.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Bisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.